Literature DB >> 32363706

Bronchoscopic interventions for severe emphysema: Where are we now?

Pallav L Shah1,2,3, Dirk-Jan Slebos4,5.   

Abstract

Patients with severe emphysema have limited treatment options and only derive a small benefit from optimal medical treatment. The only other therapy to have significant clinical beneficial effect in emphysema is LVRS but the perceived risk and invasiveness of surgery has fuelled bronchoscopic approaches to induce lung volume reduction. There are multiple bronchoscopic methods for achieving volume reduction in severe emphysema: EBV, airway bypass procedure, endobronchial coils, thermal (vapour) sclerosis and chemical sclerosis (sealants). Optimal patient selection is key to successful patient outcomes. This review discusses bronchoscopic approaches for emphysema treatment which has progressed through clinical trials to clinical practice.
© 2020 The Authors. Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology.

Entities:  

Keywords:  bronchoscopy; chronic obstructive pulmonary disease; emphysema; lung volume reduction

Mesh:

Substances:

Year:  2020        PMID: 32363706     DOI: 10.1111/resp.13835

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  3 in total

Review 1.  Endobronchial Valves for the Treatment of Advanced Emphysema.

Authors:  Karin Klooster; Dirk-Jan Slebos
Journal:  Chest       Date:  2020-12-17       Impact factor: 9.410

2.  Endoscopic lung volume reduction with endobronchial valves in very low D LCO patients: results from the German Registry - Lungenemphysemregister e.V.

Authors:  Pavlina Lenga; Christoph Ruwwe-Glösenkamp; Christian Grah; Joachim Pfannschmidt; Jens Rückert; Stephan Eggeling; Sven Gläser; Bernd Schmidt; Paul Schneider; Sylke Kurz; Gunda Leschber; Andreas Gebhardt; Birgit Becke; Olaf Schega; Jakob Borchardt; Ralf-Harto Hübner
Journal:  ERJ Open Res       Date:  2021-01-25

3.  Expeditious Resolution of Giant Bullae with Endobronchial Valves and Percutaneous Catheter Insertion.

Authors:  Yunjoo Im; Byeong-Ho Jeong; Hye Yun Park; Tae Sung Kim; Hojoong Kim
Journal:  Yonsei Med J       Date:  2022-02       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.